We next applied the shared GBM Hypoxia gene signature to recent single-cell RNA-seq (scRNA-seq) data of high-grade glioma patients that included 5 IDH-wildtype and 6 IDH-mutant gliomas11. The gene discussed is IDH1; the disease is central nervous system cancer.